Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-19 Sale | 2026-08-20 6:26 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 100,000 | $60.88 | $6,087,773 | 961,194 (Direct) | View |
| 2026-05-28 Sale | 2026-05-29 4:16 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 120,000 | $31.88 | $3,825,717 | 833,694 (Direct) | View |
| 2025-06-03 Sale | 2025-06-05 5:15 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 210,000 | $17.11 | $3,592,611 | 2,873,513 (Direct) | View |
| 2022-09-22 Purchase | 2022-09-23 10:58 am | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN Chief Executive Officer | 10,000 | $2.1042 | $21,042 | 1,064,940 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-31 Option Award | 2026-08-04 5:01 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 128,985 | $0 | 128,985 (Direct) | View |
| 2026-07-12 Exercise | 2026-07-14 5:28 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 227,500 | $0 | 1,061,194 (Direct) | View |
| 2026-07-14 Exercise | 2026-07-14 5:28 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 200,000 | $1.37 | 1,061,194 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:04 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 258,563 | $0 | 9,084,407 (Direct) | View |
| 2026-01-01 Tax Withholding | 2026-01-14 6:04 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 5,015 | $15.39 | 9,084,407 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-12 4:54 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 6,732 | $16.83 | 2,894,281 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:18 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 179,473 | $0 | 179,473 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:19 pm | N/A 2034-02-12 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 438,633 | $0 | 2,473,014 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-03 4:10 pm | N/A 2033-02-19 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 350,381 | $0 | 1,951,881 (Direct) | View |
| 2022-07-12 Option Award | 2022-07-18 4:36 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN Chief Executive Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-02-07 Option Award | 2022-02-28 4:27 pm | N/A 2032-02-07 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 416,500 | $0 | 1,601,500 (Direct) | View |